Tenaya Therapeutics, Inc. files DEF 14A

Tenaya Therapeutics, Inc. is holding its annual meeting on May 27, 2026, to elect three Class II directors, ratify its independent auditor, and approve an amendment to its 2021 Equity Incentive Plan. The proposed amendment would increase the number of shares reserved for issuance by approximately 3% of outstanding shares and remove the 4 million share annual limit from the "evergreen" provision.